ES2178461T3 - Medicamento homeopatico que comprende uno o varios componentes del nacar tal como el bioaragonito. - Google Patents

Medicamento homeopatico que comprende uno o varios componentes del nacar tal como el bioaragonito.

Info

Publication number
ES2178461T3
ES2178461T3 ES99941680T ES99941680T ES2178461T3 ES 2178461 T3 ES2178461 T3 ES 2178461T3 ES 99941680 T ES99941680 T ES 99941680T ES 99941680 T ES99941680 T ES 99941680T ES 2178461 T3 ES2178461 T3 ES 2178461T3
Authority
ES
Spain
Prior art keywords
bioaragonite
nacar
miscellaneous components
homeopathic drug
menopause
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99941680T
Other languages
English (en)
Inventor
Jean-Pierre Lablanchy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCS FRASSANITO ET CIE
Original Assignee
SCS FRASSANITO ET CIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCS FRASSANITO ET CIE filed Critical SCS FRASSANITO ET CIE
Application granted granted Critical
Publication of ES2178461T3 publication Critical patent/ES2178461T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Medicamento homeopático, caracterizado porque comprende bioaragonito de nácar, hecho compatible por inhibición de la parte más inmunógena de la sustancia orgánica a una dilución mínima de 1DH.
ES99941680T 1998-08-27 1999-08-26 Medicamento homeopatico que comprende uno o varios componentes del nacar tal como el bioaragonito. Expired - Lifetime ES2178461T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810857A FR2782641B1 (fr) 1998-08-27 1998-08-27 Medicament homeopathique comprenant un ou plusieurs composants de la nacre

Publications (1)

Publication Number Publication Date
ES2178461T3 true ES2178461T3 (es) 2002-12-16

Family

ID=9529982

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99941680T Expired - Lifetime ES2178461T3 (es) 1998-08-27 1999-08-26 Medicamento homeopatico que comprende uno o varios componentes del nacar tal como el bioaragonito.

Country Status (8)

Country Link
US (1) US20020160051A1 (es)
EP (1) EP1107771B1 (es)
AT (1) ATE218876T1 (es)
CA (1) CA2352480A1 (es)
DE (1) DE69901843T2 (es)
ES (1) ES2178461T3 (es)
FR (1) FR2782641B1 (es)
WO (1) WO2000012104A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2946883B1 (fr) * 2009-06-22 2012-04-13 Newco Brevets Produit et procede pour ameliorer la fertilite des mammiferes
US9603898B2 (en) 2011-03-23 2017-03-28 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
FR3037801B1 (fr) * 2015-06-23 2017-08-11 Jd Invest Materiau semi-synthetique pulverulent, obtenu par modification de la composition d'un biomateriau naturel marin, son procede de fabrication, ses applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01117833A (ja) * 1987-10-29 1989-05-10 Masatoshi Kato 生物活性物質
FR2742661B1 (fr) * 1995-12-21 1998-07-10 Texinfine Sa Nouvelle utilisation de compositions contenant de la nacre

Also Published As

Publication number Publication date
FR2782641A1 (fr) 2000-03-03
US20020160051A1 (en) 2002-10-31
DE69901843T2 (de) 2003-01-23
EP1107771A1 (fr) 2001-06-20
WO2000012104A1 (fr) 2000-03-09
DE69901843D1 (de) 2002-07-18
EP1107771B1 (fr) 2002-06-12
FR2782641B1 (fr) 2002-05-10
CA2352480A1 (fr) 2000-03-09
ATE218876T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
HUP0103182A2 (hu) Dialkil-fumarátok alkalmazása transzplantációs kezelésekben használható gyógyászati készítmények előállítására
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE241353T1 (de) Fumarsäurederivate zur behandlung der transplantatabstossung
BRPI0416743A (pt) formulação farmacêutica, e, métodos de preparar uma formulação de peptìdeo apropriada para uso em um dispositivo de injeção, para reduzir depósitos em equipamento de produção e no produto final, e para reduzir o entupimento de dispositivos de injeção por uma formulação de peptìdeo
BRPI0514199A (pt) método de efetuar profilaxia ou tratar uma doença, composição farmacêutica, anticorpo monoclonal, célula de hibridoma, e, método de triar um agente, de humanizar anticorpo monoclonal 8a5 ou anticorpo monoclonal 6h7 e de produzir uma forma quimérica de anticorpo monoclonal 8a5 ou anticorpo monoclonal 6h7
DE60216139D1 (de) Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
MX9206456A (es) Nuevos hibridos transformadores de los factores de crecimiento.
EA200600921A1 (ru) Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
BR0310087A (pt) Veìculos sólidos injetáveis para ácido hialurÈnico para aplicação de proteìnas osteogênicas
MX2023010711A (es) Fenalquilaminas y métodos de preparación y uso de las mismas.
ATE438618T1 (de) Inhibitoren von humanem adam-10
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
ATE383853T1 (de) Arylessigsäuren und verwandte verbindungen zur behandlung von alzheimer-krankheit
BRPI0407178A (pt) Composição farmacêutica osteogênica
ATE410155T1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
ATE293976T1 (de) Verbindungen enthaltend s-tofisopam sowie verwendung dieser verbindungen zur herstellung eines medikamentes zur behandlung oder prophylaxe von krämpfen und anfällen
JOP20240197A1 (ar) أشكال متعددة من الأتيكابرانت للاستخدام في علاج اضطراب الاكتئاب الشديد
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
ES2178461T3 (es) Medicamento homeopatico que comprende uno o varios componentes del nacar tal como el bioaragonito.
DE602004015307D1 (de) Verwendung von tigecyclin, allein oder in kombination mit rifampin zur behandlung von osteomyelitis und/oder septischer arthritis